Squarepoint Ops LLC G1 Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $186,769 - $429,570	88,938 Added 548.39%	105,156 $454,000
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $18,164 - $60,493	16,218 New	16,218 $49,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $56,177 - $178,369	-21,859 Reduced 44.33%	27,455 $73,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $5,880 - $15,295	1,133 Added 2.35%	49,314 $267,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $140,908 - $463,062	27,255 Added 130.24%	48,181 $602,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $34,772 - $73,245	8,607 Added 69.87%	20,926 $103,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $19,152 - $27,770	-2,520 Reduced 16.98%	12,319 $94,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $150,764 - $239,946	14,839 New	14,839 $152,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $122,809 - $209,690	-9,332 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $182,627 - $245,618	9,332 New	9,332 $205,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $209,536 - $388,440	-11,919 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $1.02 Million - $1.89 Million	-92,549 Reduced 88.59%	11,919 $214,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $962,207 - $1.98 Million	83,308 Added 393.71%	104,468 $1.21 Million
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $324,652 - $826,727	-33,924 Reduced 61.59%	21,160 $513,000
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $321,676 - $933,465	35,466 Added 180.78%	55,084 $607,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $272,216 - $410,843	-13,253 Reduced 40.32%	19,618 $519,000
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $593,806 - $1.06 Million	26,067 Added 383.11%	32,871 $749,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $109,068 - $211,604	6,804 New	6,804 $209,000
Q1 2019 May 15, 2019	SELL	$14.4 - $21.45 $896,155 - $1.33 Million	-62,233 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $520,031 - $1.62 Million	31,498 Added 102.48%	62,233 $1.19 Million
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $536,570 - $845,206	12,435 Added 67.95%	30,735 $1.61 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $641,598 - $936,411	18,300 New	18,300 $795,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account